Logo image of RBLX

ROBLOX CORP -CLASS A (RBLX) Stock Fundamental Analysis

NYSE:RBLX - New York Stock Exchange, Inc. - US7710491033 - Common Stock - Currency: USD

57.17  -1.4 (-2.39%)

After market: 57.04 -0.13 (-0.23%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to RBLX. RBLX was compared to 72 industry peers in the Entertainment industry. The financial health of RBLX is average, but there are quite some concerns on its profitability. RBLX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

RBLX had negative earnings in the past year.
RBLX had a positive operating cash flow in the past year.
RBLX had negative earnings in each of the past 5 years.
In the past 5 years RBLX always reported a positive cash flow from operatings.
RBLX Yearly Net Income VS EBIT VS OCF VS FCFRBLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

The Return On Assets of RBLX (-13.04%) is worse than 69.44% of its industry peers.
Looking at the Return On Equity, with a value of -422.40%, RBLX is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -13.04%
ROE -422.4%
ROIC N/A
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
RBLX Yearly ROA, ROE, ROICRBLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

RBLX has a Gross Margin of 77.76%. This is amongst the best in the industry. RBLX outperforms 90.28% of its industry peers.
RBLX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for RBLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
RBLX Yearly Profit, Operating, Gross MarginsRBLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

5

2. Health

2.1 Basic Checks

RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RBLX has been increased compared to 1 year ago.
Compared to 5 years ago, RBLX has more shares outstanding
RBLX has a better debt/assets ratio than last year.
RBLX Yearly Shares OutstandingRBLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
RBLX Yearly Total Debt VS Total AssetsRBLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.54 indicates that RBLX is not a great score, but indicates only limited risk for bankruptcy at the moment.
RBLX's Altman-Z score of 2.54 is amongst the best of the industry. RBLX outperforms 81.94% of its industry peers.
RBLX has a debt to FCF ratio of 1.57. This is a very positive value and a sign of high solvency as it would only need 1.57 years to pay back of all of its debts.
RBLX has a Debt to FCF ratio of 1.57. This is amongst the best in the industry. RBLX outperforms 80.56% of its industry peers.
A Debt/Equity ratio of 4.54 is on the high side and indicates that RBLX has dependencies on debt financing.
The Debt to Equity ratio of RBLX (4.54) is worse than 72.22% of its industry peers.
Even though the debt/equity ratio score it not favorable for RBLX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF 1.57
Altman-Z 2.54
ROIC/WACCN/A
WACC8.81%
RBLX Yearly LT Debt VS Equity VS FCFRBLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.02 indicates that RBLX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.02, RBLX perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that RBLX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.02, RBLX is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
RBLX Yearly Current Assets VS Current LiabilitesRBLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

6

3. Growth

3.1 Past

RBLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.06%, which is quite impressive.
The Revenue has grown by 28.68% in the past year. This is a very strong growth!
Measured over the past years, RBLX shows a very strong growth in Revenue. The Revenue has been growing by 47.93% on average per year.
EPS 1Y (TTM)24.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.54%
Revenue 1Y (TTM)28.68%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%20.84%

3.2 Future

Based on estimates for the next years, RBLX will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.71% on average per year.
Based on estimates for the next years, RBLX will show a quite strong growth in Revenue. The Revenue will grow by 11.75% on average per year.
EPS Next Y-5.67%
EPS Next 2Y5.38%
EPS Next 3Y10.71%
EPS Next 5YN/A
Revenue Next Year21.19%
Revenue Next 2Y20.62%
Revenue Next 3Y20.05%
Revenue Next 5Y11.75%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RBLX Yearly Revenue VS EstimatesRBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
RBLX Yearly EPS VS EstimatesRBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5

1

4. Valuation

4.1 Price/Earnings Ratio

RBLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RBLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBLX Price Earnings VS Forward Price EarningsRBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as RBLX.
Industry RankSector Rank
P/FCF 59.49
EV/EBITDA N/A
RBLX Per share dataRBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.38%
EPS Next 3Y10.71%

0

5. Dividend

5.1 Amount

No dividends for RBLX!.
Industry RankSector Rank
Dividend Yield N/A

ROBLOX CORP -CLASS A

NYSE:RBLX (3/7/2025, 8:04:01 PM)

After market: 57.04 -0.13 (-0.23%)

57.17

-1.4 (-2.39%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners77.02%
Inst Owner Change7.2%
Ins Owners5.75%
Ins Owner Change-0.38%
Market Cap38.15B
Analysts75.9
Price Target68.05 (19.03%)
Short Float %3.61%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.94%
Min EPS beat(2)13.59%
Max EPS beat(2)28.29%
EPS beat(4)4
Avg EPS beat(4)20.5%
Min EPS beat(4)13.59%
Max EPS beat(4)28.29%
EPS beat(8)6
Avg EPS beat(8)11.79%
EPS beat(12)7
Avg EPS beat(12)-0.2%
EPS beat(16)8
Avg EPS beat(16)-45.05%
Revenue beat(2)1
Avg Revenue beat(2)2.8%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)8.2%
Revenue beat(4)2
Avg Revenue beat(4)1.99%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)8.2%
Revenue beat(8)3
Avg Revenue beat(8)0.81%
Revenue beat(12)3
Avg Revenue beat(12)-6.97%
Revenue beat(16)3
Avg Revenue beat(16)-12.59%
PT rev (1m)11.34%
PT rev (3m)21.02%
EPS NQ rev (1m)2.03%
EPS NQ rev (3m)9.98%
EPS NY rev (1m)-4.47%
EPS NY rev (3m)-4.88%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)0.35%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.59
P/FCF 59.49
P/OCF 46.39
P/B 172.27
P/tB 836.52
EV/EBITDA N/A
EPS(TTM)-1.42
EYN/A
EPS(NY)-1.5
Fwd EYN/A
FCF(TTM)0.96
FCFY1.68%
OCF(TTM)1.23
OCFY2.16%
SpS5.4
BVpS0.33
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.04%
ROE -422.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.76%
FCFM 17.8%
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF 1.57
Debt/EBITDA N/A
Cap/Depr 79.94%
Cap/Sales 5.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 2.54
F-Score6
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)189.75%
Cap/Depr(5y)192.24%
Cap/Sales(3y)12.06%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.54%
EPS Next Y-5.67%
EPS Next 2Y5.38%
EPS Next 3Y10.71%
EPS Next 5YN/A
Revenue 1Y (TTM)28.68%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%20.84%
Revenue Next Year21.19%
Revenue Next 2Y20.62%
Revenue Next 3Y20.05%
Revenue Next 5Y11.75%
EBIT growth 1Y15.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year190.43%
EBIT Next 3Y53.49%
EBIT Next 5Y30.88%
FCF growth 1Y417.12%
FCF growth 3Y4.75%
FCF growth 5Y113.37%
OCF growth 1Y79.47%
OCF growth 3Y7.65%
OCF growth 5Y52.65%